Long MannKind's Afrezza: Shares Versus A Bull Call Spread
Long MannKind's Afrezza: Shares Versus A Bull Call Spread Seeking Alpha
View Article2 Risks That Could Crush MannKind in 2013
2 Risks That Could Crush MannKind in 2013 Motley Fool
View ArticleMannKind Earnings Call Insights: Partnership Status and AFREZZA
MannKind Earnings Call Insights: Partnership Status and AFREZZA Wall St. Cheat Sheet
View Article3 Events Biotech Investors Need to Watch in 2013
3 Events Biotech Investors Need to Watch in 2013 Motley Fool
View ArticleMannKind's Afrezza Likely To Fail AFFINITY 1 Phase III Trial
MannKind's Afrezza Likely To Fail AFFINITY 1 Phase III Trial Seeking Alpha
View ArticleMannKind's Afrezza Likely To Easily Gain Approval
MannKind's Afrezza Likely To Easily Gain Approval Seeking Alpha
View ArticleMannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It
MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It TheStreet.com
View ArticleMannKind's Afrezza And The Oramed Threat
MannKind's Afrezza And The Oramed Threat Seeking Alpha
View ArticleThe Run-Up Trade: Biodel's Insulin Trial Results
The Run-Up Trade: Biodel's Insulin Trial Results TheStreet.com
View ArticleMannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1...
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes Yahoo
View ArticleBiotech Stock Mailbag: 2013 Clinical Trials Calendar
Biotech Stock Mailbag: 2013 Clinical Trials Calendar TheStreet.com
View ArticleCan Mannkind Deliver A Summer Blockbuster?
Can Mannkind Deliver A Summer Blockbuster? Seeking Alpha
View Article2 Biotech Approval Outcomes That Might Affect You
2 Biotech Approval Outcomes That Might Affect You Motley Fool
View ArticleSummer Street 'much more optimistic' about MannKind approval
Summer Street 'much more optimistic' about MannKind approval The Fly on the Wall
View Article
